Filter
1003
Filtered Results: 1003
Text search:
specificty
Featured
Recommendations
119
New Publications
231
Language
Document type
No document type
579
Guidelines
187
Studies & Reports
130
Manuals
55
Strategic & Response Plan
17
Fact sheets
17
Training Material
12
Resource Platforms
4
Situation Updates
2
Countries / Regions
India
68
Global
40
South Africa
22
Africa
19
Tanzania
17
Western and Central Europe
16
Ethiopia
13
Nepal
13
Nigeria
12
Uganda
12
Kenya
12
Ghana
11
Philippines
11
Latin America and the Carribbean
11
Bangladesh
10
West and Central Africa
9
Sierra Leone
8
Brazil
8
Ukraine
8
Myanmar / Burma
8
Middle East and North Africa
8
Liberia
7
Zimbabwe
7
Zambia
7
East and Southern Africa
7
Congo, Democratic Republic of
6
USA
5
Germany
5
Syria
5
Rwanda
5
Mozambique
5
Eastern Europe
5
Russia
5
Cameroon
4
Pakistan
4
Malawi
4
Namibia
4
South–East Asia Region
4
Asia
4
Burkina Faso
3
Senegal
3
Haiti
3
Jordan
3
Lebanon
3
Cambodia
3
Thailand
3
Indonesia
3
Sudan
3
Argentina
3
Yemen
3
Eastern Europe and Central Asia
3
Venezuela
3
North America
3
Portugal
3
Iraq
2
Afghanistan
2
Turkey
2
Chad
2
China
2
Botswana
2
Angola
2
Palestine
2
Georgia
2
Vietnam
2
United Kingdom
2
Spain
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Somalia
1
South Sudan
1
Egypt
1
Central African Republic
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Hungary
1
Colombia
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Madagascar
1
Lesotho
1
Mexico
1
Sri Lanka
1
Chile
1
Western Pacific Region
1
Other region
1
Djibouti
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Moldova
1
Iran
1
Kyrgyzstan
1
Uruguay
1
Jamaica
1
France
1
Norway
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
256
Clinical Guidelines
155
Public Health
43
Pharmacy & Technologies
43
Women & Child Health
38
Key Resources
32
Capacity Building
9
Toolboxes
TB
120
HIV
92
Mental Health
84
COVID-19
80
NTDs
69
Rapid Response
57
Zika
25
Ebola
24
Planetary Health
19
NCDs
19
Disability
17
Conflict
16
AMR
16
Pharmacy
16
Refugee
14
Caregiver
12
Cholera
10
Natural Hazards
7
Global Health Education
7
Polio
6
Specific Hazards
6
Health Financing Toolbox
3
Social Ethics
2
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Revised and expanded version of the Guidelines
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
Every day in 2020, approximately 800 women died from preventable causes related to pregnancy and childbirth - meaning that a woman dies around every two minutes.
Sustainable Development Goal (SDG) target 3.1 is to reduce maternal mortality to less than 70 maternal deaths per 100 000 live births by ...
Leptospirosis is an infectious disease caused by pathogenic organisms belonging to the genus Leptospira, that are transmitted directly or indirectly from animals to humans. Leptospirosis is a major direct zoonosis. Humanto-human transmission occurs only very rarely.
